Disclosures for "Paving the Way for a New Local Peripheral Neuropathic Pain Treatment: Proof-of-Concept Clinical Trial With IncobotulinumtoxinA (PaiNT)"
-
Dr. Attal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grunenthal. Dr. Attal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merz . Dr. Attal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz . Dr. Attal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Maxona . Dr. Attal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grunenthal . Dr. Attal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medtronic . Dr. Attal has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier . Dr. Attal has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolter Kluwers.
-
Irena Pulte has received personal compensation for serving as an employee of Merz Pharmaceuticals . Irena Pulte has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Bicker has received personal compensation for serving as an employee of Merz Therapeutics GmbH. Dr. Bicker has received intellectual property interests from a discovery or technology relating to health care.
-
Prof. Finnerup has received personal compensation in the range of $0-$499 for serving as a Consultant for NeuroPN, Saniona, PharmNovo, Tris Pharma. Prof. Finnerup has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for IASP.
-
Dr. Geister has received personal compensation for serving as an employee of Merz Therapeutics GmbH.
-
Prof. VIEL has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grünenthal company. Prof. VIEL has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merz pharmaceutical. The institution of Prof. VIEL has received research support from Merz therapeutics.